EANS-Adhoc: LifeWatch AG / LifeWatch to report on Fourth Quarter and Full Fiscal Year 2012 Results on February 26, 2013 (with document)

--------------------------------------------------------------------------------
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
distribution. The issuer is solely responsible for the content of this
announcement.
--------------------------------------------------------------------------------

Annual Reports/quarterly report/ Invitation to Analyst and Media
Conference 06.02.2013

- Press release and Letter to Shareholders at 7:00 a.m. CET (01:00
a.m. EST) - Analyst and Media Conference in Zurich at 10:00 a.m. CET
- International Conference Call / Audio web cast at 10:00 a.m. CET

Neuhausen am Rheinfall/Switzerland - LifeWatch AG (SIX Swiss
Exchange: LIFE) will report on its results for the fourth quarter
2012 and full fiscal year 2012 on Tuesday, February 26, 2013.

You will find a PDF-version of this press release and of the
registration form at the end of this message.

Press release and Letter to Shareholders at 7:00 a.m. CET (1:00 a.m.
EST) LifeWatch will publish internationally the results for the
fourth quarter 2012 and full fiscal year 2012 in a press release and
letter to shareholders at 7:00 a.m. CET.

Analyst and media conference at 10:00 a.m. CET

LifeWatch will report on the fourth quarter and full fiscal year 2012
results at an English-speaking analyst and media conference that will
take place in Zurich on

Tuesday, February 26, 2013; at 10:00 a.m. CET
at the Zunfthaus zur Saffran, Limmatquai 54, 8001 Zurich/Switzerland

Please confirm your participation at the analyst and media conference
by returning the registration form by Friday, February 22, 2013.

International conference call / audio web cast at 10:00 a.m. CET

At 10:00 a.m. CET, LifeWatch will also discuss the results in a
conference call and audio web cast which will be accompanied by
presentation visuals. The conference call is also accessible as an
audio web cast in the Investor Relations section of the LifeWatch
website www.irlifewatch.com where an archived version will remain
available for download.

The local dial-in numbers for the conference call are as follows:
+ 41 (0)91 610 56 00 (Europe)
+ 44 (0)203 059 58 62 (UK)
+ 1 (1)866 291 41 66 (USA - Toll-free)

All participants are requested to dial in at least ten minutes prior
to the call. No PIN is required to access the call.

end of ad-hoc-announcement ==========================================
====================================== About LifeWatch AG: LifeWatch
AG, headquartered in Neuhausen am Rheinfall and listed on SIX Swiss
Exchange (LIFE), Switzerland, is the leading healthcare technology
and solution company, specializing in advanced telehealth systems and
wireless remote patient monitoring services. LifeWatch services cater
to individuals, ranging from high-risk and chronically ill patients,
to consumers of health and wellness products. LifeWatch AG has
operative subsidiaries in the United States, in Switzerland and in
Israel and is the parent company of LifeWatch Services Inc., and
LifeWatch Technologies, Ltd. LifeWatch Services, Inc. is a leading
US-based provider of cardiac monitoring services and home sleep
testing of Obstructive Sleep Apnea (OSA). LifeWatch Technologies
Ltd., based in Israel, is a leading developer and manufacturer of
telemedicine products. The Company is planning to introduce the
LifeWatch V, an Android-based smartphone with medical sensors and
apps that uses a cloud-based service platform. For additional
information, please visit www.lifewatch.com.

Sign-up for customized E-mail alerts and documentation requests is
available at http://production.investis.com/lifewatch/alert-service/

This press release includes forward-looking statements. All
statements other than statements of historical facts contained in
this press release, including statements regarding future results of
operations and financial position, business strategy and plans and
objectives for future operations, are forward-looking statements. The
words "believe," "may," "will," "estimate," "continue," "anticipate,"
"intend," "expect" and similar expressions are intended to identify
forward-looking statements. LifeWatch AG has based these
forward-looking statements largely on current expectations and
projections about future events and financial trends that it believes
may affect the financial condition, results of operations, business
strategy, short term and long term business operations and
objectives, and financial needs. These forward-looking statements are
subject to a number of risks, uncertainties and assumptions. In light
of these risks, uncertainties and assumptions, the forward-looking
events and circumstances described may not occur and actual results
could differ materially and adversely from those anticipated or
implied in the forward-looking statements. All forward-looking
statements are based only on data available to LifeWatch AG at the
time of the issue of this press release. LifeWatch AG does not
undertake any obligation to update any forward-looking statements
contained in this press release as a result of new information,
future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF
AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR
PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS
PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH
AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN
INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH
AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE
SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN
REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE
OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S.
PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE
REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY
PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE
MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG
OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED
INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL
STATEMENTS OF THE ISSUER.

Attachments with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/us/Ojrskc2e
http://resources.euroadhoc.com/us/YxkzoEfd

Further inquiry note:
For further information please contact:
Sensus Communication Consultants, Zürich
Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | Email lifewatch@sensus.ch

end of announcement euro adhoc
--------------------------------------------------------------------------------

Attachments with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/us/Ojrskc2e
http://resources.euroadhoc.com/us/YxkzoEfd

issuer: LifeWatch AG
Rundbuckstrasse 6
CH-8212 Neuhausen am Rheinfall
phone: +41 52 632 00 50
FAX: +41 52 632 00 51
mail: users@lifewatch.com
WWW: www.lifewatch.com
sector: Healthcare Providers
ISIN: CH0012815459
indexes: SPI, SPIEX
stockmarkets: free trade: Berlin, Open Market / XETRA: Frankfurt, Main Standard:
SIX Swiss Exchange
language: English